Dasatinib
| Use attributes for filter ! | |
| Molar mass | 488. 01 g/mol |
|---|---|
| CAS ID | 302962-49-8 |
| Protein binding | 96% |
| Formula | C22H26ClN7O2S |
| Trade name | Sprycel, Dasanix |
| Elimination half-life | 1. 3 to 5 hours |
| License data | EMA |
| US | |
| FDA | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951099 |
About Dasatinib
Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.